Vaccination therapy against malignant glioma using apoptosis-inducing genes
Vaccination therapy against malignant glioma using apoptosis-inducing genes
批准号:
07407038
负责人:
ASAI Akio
金额:
$23.23万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We cloned several genes whose expression level increase or decrease along with the progression of myc-induced apoptosis in glioma cells by differential display PCR method. One of the genes was calmodulin. Therefore, in this study, we hypothesized that calciummediated signal transduction may be involved in apoptosis and the activation of immunogenicity in malignant glioma cells and tried to investigate their molecular mechanism by confirming the hypothesis. Although we have not reached the final goal, we have found the following several important findingsregarding molecular mechanisms of apoptosis : (1) the expression level of calcineurin is extremely high in the brain as was reported ; (2)when the activity of calcineurin increases, the activity of proteasome decreases ; (3)when the proteasome activity was perturbed by inhibitors, apoptosis is induced in the cells ; (4)as a result, the cells with high calcineurin activity are vulnerable to apoptosis. These results may elucidate that hippocampal CA1 neurons with high calcineurin expression are vulnerable to delayd neuronal death induced by transient iscemia although these results are not exclusive to neural cells. It is probable that gliomaspecific mechanisms such as sctivation of tumor-immunogenicity are located downstream of the proteasome function. It is extremely important to clarify the function of proteasome in apoptosis and activation of tumor-immunogenicity and such a project is in progress.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
浅井昭雄: "グリオーマ細胞におけるアポトーシスと免疫原性変化の誘導" 脳神経外科. 23. 7-15 (1995)
Akio Asai:“神经胶质瘤细胞凋亡和免疫原性变化的诱导”《神经外科》23. 7-15 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asai A, et al.: "Abundant expression of translation initiation factor EIF-4E in post-meiotic germ cells of the rat testis." Lab Invest. 72. 890-898 (1995)
Asai A 等人:“翻译起始因子 EIF-4E 在大鼠睾丸减数分裂后生殖细胞中大量表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asai A, et al.: "Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression:differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation" Oncogene. 15. 1471-1480 (1997)
Asai A 等人:“Bax 过表达诱导的 COS-7 细胞的 Caspase 依赖性凋亡:Bcl-2 和 Bcl-xL 对 Bax 诱导的 caspase 激活的差异作用”Oncogene。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asai A,et al.: "s-Myc acts as a transcriptional activator and its sequence-specific DNA binding is required for induction of programd cell death in glioma cells." Cell Death Differ. 2. 123-131 (1995)
Asai A 等人:“s-Myc 充当转录激活剂,其序列特异性 DNA 结合是诱导神经胶质瘤细胞程序性细胞死亡所必需的。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asai A, et al.: "s-Myc acts as a transcriptional activator and its sequence-specific DNA binding is required for induction of programmed cell death in glioma cells." Cell Death Differ. 2. 123-131 (1995)
Asai A 等人:“s-Myc 充当转录激活剂,其序列特异性 DNA 结合是诱导神经胶质瘤细胞程序性细胞死亡所必需的。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Functional analysis of OX40 signal in glioma cancer stem cells
-
批准号:18K08983
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2018
-
负责人:ASAI Akio
-
依托单位:
Basic research on development of dendritic cell therapy targeting glioma cancer stem cells
-
批准号:15K10346
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2015
-
负责人:ASAI Akio
-
依托单位:
Basic Research on gene transfer using gene-gun against malignant gliomas
-
批准号:10470285
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.94万
-
财政年份:1998
-
负责人:ASAI Akio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
胶质瘤中miR-93的转录调控及其促细胞周期进展的新机制
-
批准号:81101915
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:张安玲
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
胶质瘤中miR-23b介导ICAT负调控β-catenin/TCF4信号通路的新机制
-
批准号:81001128
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2010
-
负责人:韩磊
-
依托单位:
基因修饰的人脐带间充质干细胞治疗胶质瘤的实验研究
-
批准号:81001009
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:范存刚
-
依托单位:
人脑胶质瘤Aurora A基因作用及其分子机制的研究
-
批准号:81072082
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:夏之柏
-
依托单位:
胶质瘤中AKT/β-catenin信号转导通路转录调控miR-21的新机制
-
批准号:30971136
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:康春生
-
依托单位:
生物信息学筛选的miRNA对SEPT7的调控与胶质瘤恶性表型的关系研究
-
批准号:30872985
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:贾志凡
-
依托单位:
双向磷酸化调节P38MAPK信号通路在榄香烯抗脑胶质瘤增殖中的作用
-
批准号:30740027
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2007
-
负责人:徐英辉
-
依托单位:
Thalidomide增强temozolomide对恶性胶质瘤治疗作用潜在机理的研究
-
批准号:30772228
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:杨学军
-
依托单位: